Publications by authors named "Cynthia Strout"

Claim this Profile
L
Long-term safety and effectiveness of mRNA-1273 vaccine in adults: COVE trial open-label and booster phases.
Lindsey R Baden, Hana M El Sahly, Brandon Essink, Dean Follmann, Gregory Hachigian, Cynthia Strout

Nat Commun· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low-dose Oral Thimerosal for the Treatment of Oral Herpes: Clinical Trial Results and Improved Outcome After Post-hoc Analysis.
Stephen W Mamber, Thomas Hatch, Craig S Miller, John V Murray, Cynthia Strout

J Evid Based Integr Med· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and Immunogenicity of the Ad26.RSV.preF Investigational Vaccine Coadministered With an Influenza Vaccine in Older Adults.
Jerald Sadoff, Els De Paepe, Wouter Haazen, Edmund Omoruyi, Arangassery R Bastian, Cynthia Strout

J Infect Dis· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 1 Safety and Immunogenicity Study of a Quadrivalent Seasonal Flu Vaccine Comprising Recombinant Hemagglutinin-Flagellin Fusion Proteins.
Lynda Tussey, Cynthia Strout, Matthew Davis, Casey Johnson, Gregg Lucksinger

Open Forum Infect Dis· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunogenicity and safety of Fluzone(®) intradermal and high-dose influenza vaccines in older adults ≥65 years of age: a randomized, controlled, phase II trial.
Peter Tsang, Geoffrey J Gorse, Cynthia B Strout, Malcolm Sperling, David P Greenberg

Vaccine· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sequential administration of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine in pneumococcal vaccine-naïve adults 60-64 years of age.
Richard N Greenberg, Alejandra Gurtman, Robert W Frenck, Cynthia Strout, Kathrin U Jansen

Vaccine· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 3 trial evaluating the immunogenicity and safety of a three-dose BioThrax® regimen for post-exposure prophylaxis in healthy adults.
Robert J Hopkins, Cris Howard, Ericka Hunter-Stitt, Paulina E Kaptur, Brett Pleune, Cynthia Strout

Vaccine· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intradermally-administered influenza virus vaccine is safe and immunogenic in healthy adults 18-64 years of age.
Geoffrey J Gorse, Ann R Falsey, John A Fling, Terry L Poling, Cynthia B Strout

Vaccine· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and immunogenicity of an oral, replicating adenovirus serotype 4 vector vaccine for H5N1 influenza: a randomised, double-blind, placebo-controlled, phase 1 study.
Marc Gurwith, Michael Lock, Eve M Taylor, Glenn Ishioka, Jeff Alexander, Cynthia Strout

Lancet Infect Dis· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Induction of a potent immune response in the elderly using the TLR-5 agonist, flagellin, with a recombinant hemagglutinin influenza-flagellin fusion vaccine (VAX125, STF2.HA1 SI).
David N Taylor, John J Treanor, Cynthia Strout, Casey Johnson, Theresa Fitzgerald

Vaccine· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis